These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 11953668)

  • 1. Clinical applications of hematopoietic growth factors in pediatric oncology.
    Levine JE; Boxer LA
    Curr Opin Hematol; 2002 May; 9(3):222-7. PubMed ID: 11953668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of colony-stimulating factors and granulocyte transfusion in treatment options for neutropenia in children with cancer.
    Liang DC
    Paediatr Drugs; 2003; 5(10):673-84. PubMed ID: 14510625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hematopoietic growth factors in prophylaxis and therapy of infections complications in children with neutropenia].
    Lehrnbecher T
    Klin Padiatr; 2001; 213(4):212-38. PubMed ID: 11528556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myelopoietic growth factors after stem cell transplantation: does it pay.
    Cairo MS
    J Pediatr Hematol Oncol; 2001 Jan; 23(1):2-6. PubMed ID: 11196265
    [No Abstract]   [Full Text] [Related]  

  • 5. American Society of Clinical Oncology guidelines for the use of hematopoietic colony-stimulating factors.
    Ozer H
    Curr Opin Hematol; 1996 Jan; 3(1):3-10. PubMed ID: 9372045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical use of hematopoietic growth factors.
    Ganser A; Karthaus M
    Curr Opin Oncol; 1996 Jul; 8(4):265-9. PubMed ID: 8869799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of recombinant human granulocyte-macrophage colony stimulating factor for the treatment of delayed engraftment following high dose therapy and autologous hematopoietic stem cell transplantation for lymphoid malignancies.
    Vose JM; Bierman PJ; Kessinger A; Coccia PF; Anderson J; Oldham FB; Epstein C; Armitage JO
    Bone Marrow Transplant; 1991 Feb; 7(2):139-43. PubMed ID: 1675592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [G-CSF in oncology].
    Viret F; Gonçalves A; Tarpin C; Chabannon C; Viens P
    Bull Cancer; 2006 May; 93(5):463-71. PubMed ID: 16777624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor decrease febrile neutropenia after chemotherapy in children with cancer: a meta-analysis of randomized controlled trials.
    Sung L; Nathan PC; Lange B; Beyene J; Buchanan GR
    J Clin Oncol; 2004 Aug; 22(16):3350-6. PubMed ID: 15310780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematopoietic management in oncology practice. Part 1. Myeloid growth factors.
    Glaspy JA
    Oncology (Williston Park); 2003 Nov; 17(11):1593-603. PubMed ID: 14682110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
    Bruserud O; Foss B; Petersen H
    Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
    Wong SF; Chan HO
    Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of granulocyte colony-stimulating factor in hematopoietic stem cell transplantation.
    Tabbara IA; Ghazal CD; Ghazal HH
    Cancer Invest; 1997; 15(4):353-7. PubMed ID: 9246158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hematopoietic growth factors in the prevention of infections complications in children with hematologic-oncologic diseases].
    Lehrnbecher T
    Klin Padiatr; 2001 Sep; 213 Suppl 1():A88-102. PubMed ID: 11577368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the treatment of patients with HIV infection.
    Frumkin LR
    Curr Opin Hematol; 1997 May; 4(3):200-6. PubMed ID: 9209837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The therapeutic use of hematopoietic growth factors.
    Costa JJ
    J Allergy Clin Immunol; 1998 Jan; 101(1 Pt 1):1-6. PubMed ID: 9449493
    [No Abstract]   [Full Text] [Related]  

  • 17. Colony-stimulating factors after the treatment of pediatric malignant diseases.
    Schuler D
    Pediatr Hematol Oncol; 1997; 14(1):iii-v. PubMed ID: 9021806
    [No Abstract]   [Full Text] [Related]  

  • 18. Hematopoietic growth factors.
    Bociek RG; Armitage JO
    CA Cancer J Clin; 1996; 46(3):165-84. PubMed ID: 8646546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hematopoietic growth factors and autologous or allogeneic stem cell transplantation].
    Bay JO; Peffault de Latour R; Tournilhac O; Choufi B; Chassagne J
    Bull Cancer; 2006 May; 93(5):473-82. PubMed ID: 16777625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recommendation for using granulocyte and granulocyte-macrophage growth factor during anti-cancer therapy in children].
    Balwierz W; Moryl-Bujakowska A; Balwierz A; Pawińska K
    Przegl Lek; 2006; 63(1):1-6. PubMed ID: 16892890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.